Mold & CIRS Track · Webinar 1 of 4
Mold Illness & CIRS: the diagnosis your doctor is missing
Chronic Inflammatory Response Syndrome is not a fringe diagnosis — it is a biomarker-defined inflammatory cascade that occurs in the roughly one in four people whose HLA-DR/DQ genotype cannot clear biotoxins normally. It is missed because the labs that show it are not on a standard panel.
In this full-length session, Dr. Nicole Rivera walks through the real diagnostic path: what separates mold exposure from mold illness, which inflammatory markers move first, and the sequence that decides whether you are treating a building problem, an immune problem, or both.
Watch the recording, read the full transcript below, then move into the Shoemaker cluster for the biomarker detail — every link at the bottom of this page is the intended next read.
Loading webinar…
This session is for you if…
- Your bloodwork keeps coming back "normal" while you feel progressively worse
- Brain fog, air hunger, static shocks, ice-pick pain, or unusual thirst with frequent urination
- Symptoms improve when you travel and return within days of coming home
- You have been told it is anxiety, long COVID, or chronic fatigue with no testing to back it
- One person in the household is very sick and everyone else is fine
What the webinar covers
- The difference between mold exposure, mycotoxin illness, and CIRS
- Which labs actually define CIRS (and which popular tests prove nothing)
- Why a standard CBC and CMP cannot rule biotoxin illness in or out
- How exposure removal changes everything downstream of it
- What a realistic recovery timeline looks like once you are out of exposure
Find out if this is your root cause
A $47 Health Decode maps your root-cause picture before you spend on specialty panels — so you know which thread to pull first.
Frequently asked questions
Next reading
The 12 steps in order — what each one does and where patients stall.
The cheap screen and the genotype that decide whether to keep testing.
Who he is, why the biomarker spine matters, and how we run it in 2026.
Prefer the library view? Open this session in the webinar library.
More in the mold, CIRS & Klinghardt cluster
Automatically matched to the topics in this session.
C4a, TGF-β1, MMP-9, MSH, VIP, VEGF, MARCoNS, HLA-DR — what each result changes.
ContinueFree webinar on mold-driven low testosterone: why TRT stalls, which biotoxin markers suppress androgens, and the order t
ContinueThe biomarker-defined inflammatory cascade behind most unresolving mold illness.
ContinueExposure review, mycotoxin and CIRS interpretation, sequenced protocols. Virtual across the US.
ContinueSide-by-side on biomarkers, sequencing, binders, cost and who each one suits.
ContinueEach step, what it corrects, and the labs that decide when to advance.
ContinueEducational content only. Biotoxin and hormone protocols require clinician supervision and are not a diagnosis or treatment plan.